Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02805283 · ClinicalTrials.gov registry record
Dapagliflozin Patient Satisfaction Survey
A clinical trial of Diabetes Mellitus, Type 2, sponsored by AstraZeneca.
- Completed
- Registry status
- 653
- Enrollment target
- 1
- Study location
NCT02805283: Completed study of Diabetes Mellitus, Type 2, sponsored by AstraZeneca.
NCT02805283 is a study of Diabetes Mellitus, Type 2 that has completed, run by AstraZeneca. The registered enrollment target is 653 participants, below the 4,483-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02805283, a study of Diabetes Mellitus, Type 2, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 653 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the diabetes related treatment satisfaction for patients with type 2 diabetes mellitus
Primary Outcome
Condition-specific treatment satisfaction as measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ)
Conditions Studied
Study Locations (1)
Minnesota
- Reasearch Site - Eden Prairie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 653 participants |
| Start Date | 2016-06-22 |
| Est. Completion | 2018-10-29 |
What the finished NCT02805283 record still lists
NCT02805283 is an observational study that tracks outcomes without assigning an intervention. The registered 653 participants enrollment target is mid-sized for trials with a published cap, below the 4,483-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 0 interventions.
NCT02805283 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02805283 about?
NCT02805283 is a clinical study titled "Dapagliflozin Patient Satisfaction Survey". The purpose of this study is to evaluate the diabetes related treatment satisfaction for patients with type 2 diabetes mellitus
What is the current status of trial NCT02805283?
This trial is currently completed. The enrollment target is 653 participants. The study started on 2016-06-22. Estimated completion is 2018-10-29.
What conditions does trial NCT02805283 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
Who is sponsoring clinical trial NCT02805283?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02805283 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02805283's enrollment target sits among peer trials
653 59th of 348 higher than 290 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
RECRUITING · Phase 1
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06287346 · 652 participants
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
- NCT07145515 · 655 participants · NA
Enhancing Heart Allograft Function With the OCS Heart System Trial
- NCT05407129 · 656 participants · NA
Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
- NCT06127199 · 656 participants · NA
Contraceptive Efficacy Study of Ovaprene
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI